Home
LigaChem Biosciences

LigaChem Biosciences Market Share Analysis for August 2026

리가켐 바이오사이언스는 신약개발에 30년 이상 헌신하며 혁신적인 기술과 Open Innovation을 통해 글로벌 신약개발의 새로운 길을 개척하고 있습니다.

Health > Biotechnology and Pharmaceuticals

Domainligachembio.com

Year Founded2006

Employees51 - 200

Annual Revenue--

LigaChem Biosciences

LigaChem Biosciences (including company regionals)

ligachembio.com

See more website traffic and engagement information

Total visits to LigaChem Biosciences's top domains

Understand LigaChem Biosciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ligachembio.com22.6K

See more with Sales Intelligence

Avg. visit duration in LigaChem Biosciences's top domains

Analyze LigaChem Biosciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ligachembio.com00:07:13

See more with Sales Intelligence

Avg. pageviews on LigaChem Biosciences's top domains

See how LigaChem Biosciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ligachembio.com7.54

See more with Sales Intelligence

LigaChem Biosciences top competitors by domain

Top similar sites in August 2026, ranked by their affinity

arvinas.comCompany NameArvinasEmployees201 - 500HQUnited States, Connecticut, New HavenAnnual revenue$200M - $500MTotal visits12.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by LigaChem Biosciences

These are the website technologies, by industry, used by LigaChem Biosciences top domains

Mobile (3)

Meta Viewport

Widget (2)

reCAPTCHA

Conversion & Analytics (1)

Google Analytics

Marketing (1)

Google Marketing Platform

More Technologies

2

See all

News & Signals from LigaChem Biosciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBreeze Bio, Inc. partnered with LIGACHEM BIOSCIENCES Inc. on Jul 21st '26.Breezebio and Ligachem partner on cancer vaccine research.

NewsLIGACHEM BIOSCIENCES Inc. invests into Iksuda Therapeutics Limited $25M in investment.Leading South Korean antibody-drug conjugate (ADC) specialist LigaChem Biosciences has made a $25m investment for an initial 26.6% equity stake in existing partner IKSUDA Therapeutics, and secured the right to buy shares from other current major shareholders to eventually take control of the UK-based ADC specialist.

NewsWuxixdc partners with LIGACHEM BIOSCIENCES Inc..China-based WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specialising in antibody-drug conjugates (ADCs) and other bioconjugates, has announced the signing of an expanded Memorandum of Understanding (MoU) with South Korea-based LigaChem Biosciences, Inc., a leader in the development of innovative ADC therapies targeting cancer and other serious diseases.